Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRCA2 anticorps (pSer3291)

BRCA2 Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7138558
  • Antigène Voir toutes BRCA2 Anticorps
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Épitope
    • 15
    • 11
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer3291
    Reactivité
    • 56
    • 23
    • 20
    • 4
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 55
    • 7
    Lapin
    Clonalité
    • 54
    • 8
    Polyclonal
    Conjugué
    • 31
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BRCA2 est non-conjugé
    Application
    • 37
    • 16
    • 13
    • 13
    • 9
    • 6
    • 5
    • 5
    • 5
    • 4
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
    Immunogène
    Peptide sequence around phosphorylation site of Serine 3291 (F-V-S(p)-P-A) derived from Human BRCA2.
    Isotype
    IgG
    Top Product
    Discover our top product BRCA2 Anticorps primaire
  • Indications d'application
    WB:1:500-1:1000,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Autre désignation
    BRCA2 (BRCA2 Produits)
    Synonymes
    anticorps BRCC2, anticorps BROVCA2, anticorps FACD, anticorps FAD, anticorps FAD1, anticorps FANCB, anticorps FANCD, anticorps FANCD1, anticorps GLM3, anticorps PNCA2, anticorps 30169, anticorps BcDNA:SD25109, anticorps CG13583, anticorps CG13584, anticorps CG30169, anticorps Dmel\\CG30169, anticorps brca2, anticorps dmbrca2, anticorps fancd1, anticorps BRCA2, anticorps brcc2, anticorps brovca2, anticorps facd, anticorps fad, anticorps fad1, anticorps fancb, anticorps AI256696, anticorps AW045498, anticorps Fancd1, anticorps RAB163, anticorps BRCA2, DNA repair associated, anticorps Breast cancer 2, early onset homolog, anticorps breast cancer 2, early onset, anticorps BRCA2, anticorps Brca2, anticorps brca2, anticorps LOC584780
    Sujet

    Background:

    Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures.

    Wooster R., Nature 378:789-792(1995).
    Tavtigian S.V., Nat. Genet. 12:333-337(1996).
    Dunham A., Nature 428:522-528(2004).

    Aliases: BRCA 2 antibody, BRCA1/BRCA2 containing complex subunit 2 antibody, Brca2 antibody, BRCA2, DNA repair associated antibody, BRCA2_HUMAN antibody, BRCC 2 antibody, BRCC2 antibody, Breast and ovarian cancer susceptibility gene early onset antibody, breast and ovarian cancer susceptibility protein 2 antibody, Breast cancer 2 early onset antibody, Breast Cancer 2 tumor suppressor antibody, Breast cancer susceptibility protein BRCA2 antibody, Breast cancer type 2 susceptibility protein antibody, BROVCA2 antibody, FACD antibody, FAD 1 antibody, FAD antibody, FAD1 antibody, FANCB antibody, FANCD 1 antibody, FANCD antibody, FANCD1 antibody, FANCD1 gene antibody, Fanconi anemia complementation group D1 antibody, Fanconi anemia group D1 protein antibody, GLM3 antibody, mutant BRCA2 antibody, OTTHUMP00000018803 antibody, OTTHUMP00000042401 antibody, PNCA2 antibody, XRCC11 antibody

    UniProt
    P51587
    Pathways
    Réparation de l'ADN, M Phase, Maintenance of Protein Location
Vous êtes ici: